- Home
- PSNY vs TMDX Comparison
PSNY vs TMDX Comparison
Compare PSNY & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSNY
- TMDX
- Stock Information
- Founded
- PSNY 2017
- TMDX 1998
- Country
- PSNY Sweden
- TMDX United States
- Employees
- PSNY N/A
- TMDX N/A
- Industry
- PSNY Auto Manufacturing
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- PSNY Consumer Discretionary
- TMDX Health Care
- Exchange
- PSNY Nasdaq
- TMDX Nasdaq
- Market Cap
- PSNY 2.1B
- TMDX 2.3B
- IPO Year
- PSNY N/A
- TMDX 2019
- Fundamental
- Price
- PSNY $1.06
- TMDX $93.50
- Analyst Decision
- PSNY Hold
- TMDX Buy
- Analyst Count
- PSNY 7
- TMDX 10
- Target Price
- PSNY $1.29
- TMDX $118.44
- AVG Volume (30 Days)
- PSNY 3.5M
- TMDX 1.2M
- Earning Date
- PSNY 03-06-2025
- TMDX 05-08-2025
- Dividend Yield
- PSNY N/A
- TMDX N/A
- EPS Growth
- PSNY N/A
- TMDX N/A
- EPS
- PSNY N/A
- TMDX 1.01
- Revenue
- PSNY $2,046,740,000.00
- TMDX $441,540,000.00
- Revenue This Year
- PSNY N/A
- TMDX $25.33
- Revenue Next Year
- PSNY $77.28
- TMDX $20.53
- P/E Ratio
- PSNY N/A
- TMDX $92.57
- Revenue Growth
- PSNY N/A
- TMDX 82.74
- 52 Week Low
- PSNY $0.61
- TMDX $55.00
- 52 Week High
- PSNY $1.94
- TMDX $177.37
- Technical
- Relative Strength Index (RSI)
- PSNY 52.95
- TMDX 73.44
- Support Level
- PSNY $0.93
- TMDX $82.62
- Resistance Level
- PSNY $1.05
- TMDX $95.90
- Average True Range (ATR)
- PSNY 0.08
- TMDX 5.40
- MACD
- PSNY 0.01
- TMDX 1.57
- Stochastic Oscillator
- PSNY 91.30
- TMDX 92.87
About PSNY Polestar Automotive Holding UK PLC ADS
Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market-leading standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from USA.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.